MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Street Insider Logo

Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)

Bezinga Logo

Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines

Seeking Alpha logo

FDA Accepts Revance Application for Its Injection To Treat Frown Lines

Realself Logo

How Beauty Innovations Are Approved Here and Abroad – Plus the Global Game Changers Doctors are Buzzing About

Allure Logo

What’s The Deal With DAXI, The Neuromodulator Everyone’s Talking About

Nashville Post Logo

Nashville Post: 2022 NAIOP award winners announced